Even as Wegovy rides high, interest surges in weight loss drugs that preserve muscle; A digital pill shows early promise in detecting opioid overdose, sleep apnea

Taking stock of the drug industry, from the lab to the medicine chest

November 17, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Even as Wegovy rides high, interest surges in weight loss drugs that preserve muscle STAT Obesity Drug Tracker update: Companies turn to developing weight loss drugs that conserve muscle even as they erode fat. By Allison DeAngelis and Elaine Chen STAT+ | A digital pill shows early promise in detecting opioid overdose, sleep apnea A research team tested its swallowable sensor in humans for the first time, showing early promise in measuring sleep apnea and overdose. By Lizzy Lawrence The return of biotech's "bump factor" amid an economic downturn Today's biotech updates include Casgevy's approval, Vertex and CRISPR, Wegovy and Zepbound studies, and more By Damian Garde

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser